Phase II Study of beta-2'-deoxythioguanosine in adult acute leukemia.
D000328:Adult; D002986:Clinical Trials as Topic; D003849:Deoxyguanosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D013872:Thionucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013872:Thionucleosides; C010438:beta-2'-deoxythioguanosine; D003849:Deoxyguanosine